/
CTEV
$34.06+$0.91 (+2.75%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$565.1M
17M shares
52-week range
$11.50 – $74.07
36% from low
Sector
SERVICES-BUSINESS SERVICES, NEC
Exchange
NYSE
CS
Borrow rate
0.95%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$13.07
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $982.9M | $937.8M | $1.12B | $1.08B | $961.5M | $930.6M | $965.4M |
| Cost of revenue | $149.5M | $149.6M | $318.7M | $175.3M | $204.1M | $235.5M | $239.4M | $698.8M |
| Gross profit | $891.4M | $833.3M | $619.1M | $942.3M | $875.6M | $726.1M | $691.2M | $266.6M |
| Gross margin | 85.6% | 84.8% | 66.0% | 84.3% | 81.1% | 75.5% | 74.3% | 27.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $427.5M | $368.2M | −$131.8M | $386.1M | −$362.7M | $162.0M | −$1.39B | $45.1M |
| EBITDA | $813.9M | $786.3M | $192.4M | $815.0M | $158.3M | $651.9M | −$1.01B | $475.4M |
| Net income | $36.2M | $9.7M | −$520.6M | $102.1M | −$572.9M | −$91.7M | −$1.65B | −$284.3M |
| Net margin | 3.5% | 1.0% | -55.5% | 9.1% | -53.1% | -9.5% | -176.9% | -29.4% |
| EPS (diluted) | 1.32 | 0.35 | -44.23 | 6.40 | -35.87 | -5.69 | -101.92 | -17.30 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $993M | $-15.93 | $-16.01–$-15.87 | 2 |
| 2027 | $1.0B | $-13.87 | $-13.95–$-13.82 | 2 |
| 2028 | $1.1B | $-13.05 | $-14.98–$-11.37 | 4 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$125.36
Price
$34.06
Implied upside
+268%
Peer comparison
Claritev Corporation
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
www.claritev.com- Employees
- 3,000
- IPO / List date
- Apr 3, 2020
- HQ
- MCLEAN, VA
Held by traders on TradeandTell
No one on the platform currently holds CTEV.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 51,915 | $848.3K |
| Third Point LLCas of 2026-03-31 | 44,000 | $719.0K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CTEV yet.
